• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLBELLA XC 2 X 1ML 32G; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLBELLA XC 2 X 1ML 32G; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 96181
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Visual Impairment (2138); Foreign Body Embolism (4439)
Event Date 03/08/2021
Event Type  Injury  
Manufacturer Narrative
The events of vascular occlusion and vision abnormalities are a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Clarification: the filler was injected into the patient and is not accessible for return.The syringe was discarded.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Health professional reported injecting a patient in the lateral half of the tear troughs with 0.3 cc of juvéderm volbella® xc on each side.That day, the patient experienced ¿vascular occlusion and some mottling to the right cheek¿ with ¿double vision¿ the next day.The patient was treated the same day with hylenex.The event is ongoing.
 
Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.Additional, changed, and/or corrected data.
 
Event Description
Health professional reported injecting a patient in the lateral half of the tear troughs with 0.3 cc of juvéderm volbella® xc on each side.That day, the patient experienced ¿vascular occlusion and some mottling to the right cheek¿ with ¿double vision¿ the next day.The patient was treated the same day with hylenex.The event is ongoing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLBELLA XC 2 X 1ML 32G
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
MDR Report Key11609223
MDR Text Key243603923
Report Number3005113652-2021-00199
Device Sequence Number1
Product Code LMH
Combination Product (y/n)Y
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 05/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/16/2022
Device Catalogue Number96181
Device Lot NumberV15LB00522
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/08/2021
Initial Date FDA Received04/02/2021
Supplement Dates Manufacturer Received04/15/2021
Supplement Dates FDA Received05/10/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SYNTHROID, MULTIVITAMINS.; SYNTHROID, MULTIVITAMINS
Patient Outcome(s) Other; Required Intervention;
-
-